PSYK ETF
Limited financial coverage for PSYK.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The fund's manager utilizes a passive investment strategy, aiming to closely mirror the returns of its target index. This benchmark is systematically constructed based on specific criteria, focusing on companies engaged in the legal development and application of psychedelic treatments for various medical conditions, adhering to the regulatory frameworks of the respective countries. Generally, the fund will acquire all of the index's constituent securities, maintaining portfolio weightings that approximate their representation within the index.
- IPO
- 2022
- HQ
- DE, US
Price Chart
- 52W High
- $19.15
- 52W Low
- $16.10
- 50D MA
- $17.49
- 200D MA
- $17.56
- Beta
- 0.00
- Avg Volume
- 21.61K
Get TickerSpark's AI analysis on PSYK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PSYK coverage
Recent articles, reports, and earnings notes.
No research on PSYK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PSYK report →Similar companies
Peers in the same neighborhood.